Navigation Links
Insulin Pump With Blood Sugar Sensor May Improve on Injections
Date:6/29/2010

By Jenifer Goodwin
HealthDay Reporter

TUESDAY, June 29 (HealthDay News) -- Type 1 diabetics who used an insulin pump and a sensor that continuously monitored their blood sugar levels had better control over their illness than people taking insulin injections, a large clinical trial finds.

Researchers divided 485 people aged 7 to 70 into two groups. One group performed multiple daily insulin injections and tested their blood sugar throughout the day, the standard treatment for type 1 diabetes.

The other group was taught to use an insulin pump and a blood glucose sensor from device maker Medtronic, which helped fund the study. The pump, about the size of a pager, delivers small amounts of insulin through a tiny tube inserted under the skin. Insulin is delivered throughout the day and can be adjusted according to food intake, while the sensor reads blood sugar levels every five minutes.

Even though the sensor can relay information to the pump, the sensor does not control the amount of insulin being delivered -- that is still calibrated and adjusted by the patient, the researchers explained. The sensor also has adjustable alarms for high and low blood sugar.

After one year, the group using the pump and sensor had significantly better blood sugar readings than those using injections, the study found.

At the start of the study, A1C levels (a measure of long-term blood sugar control) were 8.3 percent for both groups.

For those on the pump, A1C levels dropped to 7.5 percent compared to 8.1 percent for those using injections.

The A1C target for adults with diabetes is under 7 percent, while for teens the target is 7.5 percent and for children aged 6 to 12, it's 8 percent, explained study author Dr. Richard Bergenstal, executive director of the International Diabetes Center at Park Nicollet in Minneapolis and president of the American Diabetes Association. Studies suggest those thresholds can prevent many of the long-term complications of high blood sugar, while also helping to prevent dangerously low blood sugar levels.

Importantly, there was no difference in the incidence of hypoglycemia, or dangerously low blood sugar episodes, between the two groups, the authors found.

"This is a really important study that shows that a sensor and pump together can help people with type 1 diabetes in all age groups," Bergenstal said. "That children, adolescents and adults can improve their blood sugars without causing an increase in hypoglycemia or weight gain is a dramatic finding."

The study was published online June 29 in the New England Journal of Medicine and was to be presented at the American Diabetes Association annual meeting in Orlando, Fla.

The findings are especially good news for children and teens whose blood sugar can be more difficult to manage due to physiological changes and behavioral issues, Bergenstal said. A lot of teens don't want to be bothered with managing their diabetes, nor are children and teens known for thinking about the long-term implications of their behaviors.

In the study, nearly 44 percent of pediatric patients using the sensor-augmented pump achieved glucose control targets, compared to only 20 percent of pediatric patients in the injection group.

While the pump/sensor combination could improve the ability of diabetics to manage their blood sugar, the key to making the technology work are the patients who use it, said Dr. Howard Wolpert, a senior physician at the Joslin Diabetes Center in Boston.

Diabetics have to be willing to wear the devices, change the cannula (inserted tube) every few days, monitor what the sensor is telling them about their blood sugar and adjust their food intake and insulin levels accordingly, he said.

"These tools do take diabetes management to a higher level and can lower risk of long-term complications, but it's still just a tool," Wolpert said. "It's really the patient who is motivated and gets the proper guidance who can use this technology most effectively."

Short- and long-term blood sugar trends and patterns can also be downloaded from the device for viewing by the patient and doctors, Bergenstal noted.

Though often lumped together, type 1 and type 2 diabetes are in many ways different diseases. In type 1 diabetes, formerly called juvenile diabetes, the pancreas stops producing insulin, the hormone that enables the body to convert sugar and starches found in foods into energy.

About 5 percent to 10 percent of people with diabetes have type 1, according to the American Diabetes Association. Tight blood sugar control can minimize the risk of long-term complications, including kidney failure, blindness and nerve damage.

"It's important for people to realize there is a real change in the long-term outlook for the health of people with type 1 diabetes, and that's what this new technology represents," Wolpert said.

More information

The Joslin Diabetes Center has more on type 1 diabetes, and the pros and cons of using an insulin pump.

SOURCES: Richard Bergenstal, M.D., executive director, International Diabetes Center, Park Nicollet, Minneapolis, and president, American Diabetes Association; Howard Wolpert, M.D., senior physician, Joslin Diabetes Center, Boston; June 29, 2010, New England Journal of Medicine, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Sensor and insulin pump results in better blood-sugar control in all age groups with diabetes
2. Mothers high blood sugar in pregnancy is linked to childrens reduced insulin sensitivity
3. Fructose sugar makes maturing human fat cells fatter, less insulin-sensitive
4. Cutting carbs is more effective than low-fat diet for insulin-resistant women
5. Women with Polycystic Ovarian Syndrome and Insulin Resistance can Lose Weight and Balance Hormones Naturally with Katie Humphrey's New E-book
6. Diabetic potential to create own insulin
7. Nicer than needles: Insulin pills for diabetes finally in clinical trials
8. New pathway to cheap insulin
9. Mayo-led research team develop agents that keep insulin working longer
10. One Sleepless Night Ups Insulin Resistance
11. Study Finds That Insulin-Producing Beta Cells Can Be Reborn
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Insulin Pump With Blood Sugar Sensor May Improve on Injections 
(Date:5/29/2016)... ... May 29, 2016 , ... Whole Health Supply is happy to announce the ... available via Amazon.com. This new style of nail clipper has a wider jaw opening ... approximately 4mm and the actual handle is 2.5mm thick to accommodate the cutting force. ...
(Date:5/28/2016)... ... ... May 26, 2016- In search of the K. Warriors, Shaolin Institute is ... Warriors” on June 4, 2016 at Ashbury Hotel and Suites 600 West Interstate 65 ... by Shaolin Institute and sanctioned by KSF (Kungfu Sanda Federation), This is the 28th ...
(Date:5/27/2016)... Newark, NJ (PRWEB) , ... May 27, 2016 , ... ... been named as YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The ... to their workplace. For this year, Geri Boone, Director of the MLTSS (Managed Long-Term ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought ... industry, from leading advocates, associations and industry leaders such as Bioness. , ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... her award on May 18 at the university’s Student Leadership Awards ceremony. , ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... May 27, 2016 LabStyle Innovations ... Diabetes Management Tool, today announced that the Company,s Chief Financial ... MicroCap Conference being held June 1-2 in New ... held June 7-9 in Los Angeles, CA. ... recent corporate and operational milestones, including the U.S. FDA Clearance ...
(Date:5/27/2016)... TEL-AVIV, Israel , May 27, 2016 /PRNewswire/ ... KTOV), an innovative biopharmaceutical company focused on late-stage ... by Dexcel Pharma of pivotal batches ... Food and Drug Administration (FDA). This follows Kitov,s ... pivotal Phase III trial successfully met its primary ...
(Date:5/26/2016)... York , May 26, 2016 ... Research "Medical Waste Management Market - U.S. Industry Analysis, Size, ... waste management market in the U.S. was valued at US$ ... a CAGR of 3.4% from 2015 to 2023 to reach ... exhaustive analysis of current and emerging needle free drug delivery ...
Breaking Medicine Technology: